Triple-negative breast cancer patients treated with subcutaneous mastectomy with immediate reconstruction: single institution experience

Triple-negative breast cancer patients treated with subcutaneous mastectomy with immediate reconstruction: single institution experience

Saved in:

Bibliographic Details
Main Authors:	Artur Bocian, Paweł Macek, Piotr Kędzierawski
Format:	Article
Language:	English
Published:	Termedia Publishing House 2024-12-01
Series:	Menopause Review
Subjects:	combined treatment triple-negative breast cancer subcutaneous mastectomy
Online Access:	https://www.termedia.pl/Triple-negative-breast-cancer-patients-treated-with-subcutaneous-mastectomy-with-immediate-reconstruction-single-institution-experience,4,55354,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RELAPSES AFTER RADICAL SUBCUTANEOUS/SKIN-SPARING MASTECTOMY WITH SIMULTANEOUS RECONSTRUCTION IN BREAST CANCER
by: A. D. Zikiryakhodzhayev, et al.
Published: (2019-04-01)

Analysis of the breast cancer progression frequency depending on the amount of surgical treatment performed after neoadjuvant drug therapy
by: M. Yu. Rykov, et al.
Published: (2023-03-01)

Role of Axillary Lymph Nodes Involvement in Some Complications of Modified Radical Mastectomy
by: Hussein Abbas Obaid, et al.
Published: (2024-12-01)

Factors affecting quality of life in women post mastectomy for breast cancer in Baheya Foundation (Egypt): ‘A retrospective cohort study’
by: Salsabil Mohammed Abdelrahman, et al.
Published: (2025-02-01)

Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer
by: Chang Cheng, et al.
Published: (2025-01-01)

RSL3 induces ferroptosis by activating the NF-κB signalling pathway to enhance the chemosensitivity of triple-negative breast cancer cells to paclitaxel
by: Jialin Yuan, et al.
Published: (2025-01-01)

Classifications of triple-negative breast cancer: insights and current therapeutic approaches
by: Ziqi Chen, et al.
Published: (2025-02-01)

Intrinsic subtype and immunity score in identification of triple-negative breast cancer at low risk
by: Xinyu Ren, et al.
Published: (2025-04-01)

The analysis of gene co-expression network and immune infiltration revealed biomarkers between triple-negative and non-triple negative breast cancer
by: Yao Yi, et al.
Published: (2025-01-01)

Deep Learning and Radiomics in Triple-Negative Breast Cancer: Predicting Long-Term Prognosis and Clinical Outcomes
by: Cheng C, et al.
Published: (2025-01-01)

Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function
by: Annat Raiter, et al.
Published: (2025-02-01)

Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer
by: Wei Chen, et al.
Published: (2025-01-01)

The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study
by: Huayan Gu, et al.
Published: (2025-02-01)

The value of inflammation-related indicators in chemotherapy efficacy and disease-free survival of triple-negative breast cancer
by: Jie Zhu, et al.
Published: (2025-02-01)

Tumor microenvironment and immunotherapy for triple-negative breast cancer
by: Zijie Guo, et al.
Published: (2024-12-01)

Network Pharmacology, Molecular Docking, and Molecular Dynamics Analysis of Honokiol against Triple-negative Breast Cancer
by: Hassan H. Alhassan
Published: (2024-12-01)

Investigation of survival and prognostic factors in triple negative molecular subtype male breast cancer patients: A population-based study
by: Ahmet Necati Sanli, et al.
Published: (2024-04-01)

Interleukin-12 Inhibits Tumor Growth and Metastasis Promoted by Tumor-Associated Mesenchymal Stem Cells in Triple-Negative Breast Cancer
by: Babak Jahangiri, et al.
Published: (2024-09-01)

Artesunate, EDTA, and colistin work synergistically against MCR-negative and -positive colistin-resistant Salmonella
by: Yajun Zhai, et al.
Published: (2025-02-01)

Comparison of ropivacaine with ropivacaine–dexamethasone combination for postoperative analgesia in the pectoral nerve block for modified radical mastectomy: A randomized clinical trial
by: Veena Mathur, et al.
Published: (2024-12-01)

Generalized subcutaneous emphysema (pnenmoderma) in a dog
by: İlker Çamkerten, et al.

Dual Functions of Androgen Receptor Overexpression in Triple-Negative Breast Cancer: A Complex Prognostic Marker
by: Umay Kiraz, et al.
Published: (2025-01-01)

Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells
by: Sima Kianpour Rad, et al.
Published: (2025-01-01)

B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer
by: Nicole J. Toney, et al.
Published: (2025-01-01)

Functionalized biomimetic nanoparticles loaded with salvianolic acid B for synergistic targeted triple-negative breast cancer treatment
by: Nuo Cheng, et al.
Published: (2025-02-01)

CRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line
by: Amr A. Waly, et al.
Published: (2025-01-01)

Mechanistic insights into pachymic acid’s action on triple-negative breast Cancer through TOP2A targeting
by: Ming Liu, et al.
Published: (2025-01-01)

Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma: Relationship With Prognostic Factors and Response to Neoadjuvant Chemotherapy
by: Özgen Arslan Solmaz, et al.
Published: (2025-01-01)

The potential benefits of radiotherapy in elderly patients with early-stage triple-negative breast cancer
by: Zheng Xu, et al.
Published: (2025-01-01)

Accidental intra-arterial injection of enoxaparin sodium leading to abdominal wall expanding subcutaneous hematoma and abdominal wound: case report-vascular
by: Caroline Howell, et al.
Published: (2025-01-01)

A computational and structural approach to identify malignant non-synonymous FOXM1 single nucleotide polymorphisms in triple-negative breast cancer
by: Prarthana Chatterjee, et al.
Published: (2025-01-01)

The overview of modern approaches in treatment of triple negative breast cancer
by: A. A. Kharitonova, et al.
Published: (2020-03-01)

Comparative survival outcomes of neoadjuvant and adjuvant therapy in patients with T1c, node-negative, triple-negative breast cancer: A population-based analysis
by: Yi-Zi Zheng, et al.
Published: (2025-02-01)

Navigating large-volume subcutaneous injections of biopharmaceuticals: a systematic review of clinical pipelines and approved products
by: Philip Green, et al.
Published: (2024-12-01)

DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
by: Wen-yu Cai, et al.
Published: (2025-02-01)

Function of vasohibin-2 and the mechanism of alternative splicing in triple-negative breast cancer
by: WANG Wei, et al.
Published: (2024-12-01)

Telomerase and mitochondria inhibition promote apoptosis and TET2 and ANMT3a expression in triple negative breast cancer cell lines
by: Zeinab Mazloumi, et al.
Published: (2024-07-01)

Subcutaneous immunoglobulin-induced eczematous dermatitis
by: Rachel Breidbart, BS, et al.
Published: (2025-02-01)

Exploring the Prognostic Role of Trop-2, CD47, and CD163 Expression Levels on Survival Outcomes in Patients with Triple-Negative Breast Cancer
by: Ramazan Oguz Yüceer, et al.
Published: (2025-01-01)

SHP2 promotes the epithelial-mesenchymal transition in triple negative breast cancer cells by regulating β-catenin
by: Shihan Qian, et al.
Published: (2025-01-01)